Monographie - Neostigmine methylsulfate

Siste oppdatering :
08/05/2024

Neostigmine methylsulfate

Kjemisk struktur

Handelsnavn

Handelsnavn er veiledende og sammensetning av hjelpestoffer kan være forskjellig avhengig av land og produsent

Adwigmine	Egypt
Amostigmine	Egypt
Beemine	India
Bloxiverz
Epistigmine	Egypt
Fadastigmina	Argentina, Italia, Portugal
Ipostigmine	Iran
Miostin	Romania
Neostig	Tyskland
Neostigmin	Sverige, Tyskland
Neostigmina	Argentina, Chile, Colombia, Ecuador, Peru, Portugal, Spania, Venezuela
Neostigmine	Australia, Canada, Egypt, Hellas, Irland, Malaysia, Nederland, New Zealand, Saudi-Arabia, Storbritannia, Tyrkia
Neostigmine methylsulfate	Canada
Neostigten	Peru
Normastigmin	Østerrike
Planstigmin	Tyrkia
Polstigminum	Polen
Prostigmin	Belgia, Hellas, Malaysia, Nederland, Sveits, Østerrike
Prostigmina	Italia
Prostigmine	Belgia, Chile, Colombia, De forente arabiske emirater, Egypt, Frankrike, Luxembourg, Marokko, Mexico, Spania, Venezuela
Setisin	Malaysia
Stigmosan	Ungarn
Tigmin	Peru
Visulmin	Mexico

Referanser : Neostigmine methylsulfate

	Type	Publikasjon
815	Journal	Stewart JT, Warren FW, King DT, Venkateshwaran TG, Fox JL. Stability of ondansetron hydrochloride and 12 medications in plastic syringes. Am J Health-Syst Pharm 1998 ; 55: 2630-2634.
1200	Journal	Chaudry IA, Bruey KP, Hurlburt LE, Oden EM. Compatibility of netilmycin sulfate injection with commonly used intravenous injections and additives. Am J Hosp Pharm 1981 ; 38: 1737-1742.
1228	Journal	Allen LV, Stiles ML. Compatibility of various admixtures at Y-injection sites of intravenous administration sets. Part2. Am J Hosp Pharm 1981 ; 38: 380-381.
1682	Journal	Storms M, Stewart JT, Warren FW. Stability of neostigmine methylsulfate injection at ambient temperature and 4°C in polypropylene syringes. Int J Pharm Compound 2002 ; 6: 475-477.
2286	Journal	Ben M, Trusley C, Kupiec TC, Trissel LA. Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated Y-site administration. Int J Pharm Compound 2008 ; 12, 4: 368-371.
2291	Journal	Yeh MK. Degradation kinetics of neostigmine in solution. Drug Dev Ind Pharm 2000 ; 26, 11: 1221-1226.
3372	Journal	Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine. Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3578	Labratorium	Cisplatin - Summary of Product Characteristics Accord Healthcare 2011
3599	Labratorium	Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics Amco Amdipharm Mercry 2013
3644	Labratorium	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010

Mentions Légales